Exploring potential mid-trimester maternal serum biomarkers for fetal congenital heart disease: a retrospective case-control study
Objective To assess potential associations between maternal serum alpha-fetoprotein (AFP) and free human chorionic gonadotropin beta subunit (free β-hCG) levels during the mid-trimester and the occurrence of fetal congenital heart disease (CHD).Methods A retrospective case-control study was carried...
Saved in:
| Main Authors: | Yuxia Jin, Suping Li, Jing Li, Xiaojun Chai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | The Journal of Maternal-Fetal & Neonatal Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14767058.2025.2541025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Antiseizure Medications on Second-Trimester Prenatal Screening Test Parameters: A Retrospective Cohort Study
by: Melisa Golgelioglu, et al.
Published: (2025-06-01) -
Maternal serum screening for Down's syndrome on population basis
by: Riitta Salonen, et al.
Published: (1997-09-01) -
Comparison of pregnant mare serum gonadotropin products with surprising differences in protein content
by: Martina Lösle, et al.
Published: (2025-02-01) -
MicroRNAs as novel biomarkers for prenatal fetal congenital heart disease – systematic literature review
by: Adrianna Kondracka, et al.
Published: (2025-07-01) -
Predictive value of the maternal alpha-fetoprotein variant, L2, during the first trimester of pregnancy screening for fetal trisomy 21, trisomy 18, and neural tube defects
by: Yiming Chen, et al.
Published: (2025-08-01)